Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

about

Desensitized chimeric antigen receptor T cells selectively recognize target cells with enhanced antigen expression.

P2860

Q47547004-96314C5F-B396-45A1-AE5E-C15F117B1355

P2860

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

Item

http://www.wikidata.org/entity/Q45947690

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

@en

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

@nl

type

Item

label

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

@en

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

@nl

prefLabel

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

@en

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

@nl

P1476

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

@en

P2093

Gunce E Cinay

http://www.w3.org/2001/XMLSchema#string

Pin Wang

http://www.w3.org/2001/XMLSchema#string

Xiaolu Han

http://www.w3.org/2001/XMLSchema#string

Xiaoyang Zhang

http://www.w3.org/2001/XMLSchema#string

Yifan Zhao

http://www.w3.org/2001/XMLSchema#string

Yunfei Guo

http://www.w3.org/2001/XMLSchema#string

P2860

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Structures of adnectin/protein complexes reveal an expanded binding footprint

Toxicity and management in CAR T-cell therapy

Epidermal growth factor receptor mutations in lung cancer

Chimeric antigen receptor T cells for sustained remissions in leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

P304

2466-2476

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YMTHE.2017.07.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28784559

http://www.w3.org/2001/XMLSchema#string

P932

5675441

http://www.w3.org/2001/XMLSchema#string

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

about

P2860

P2860

Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932